Boc-3-Hydroxy-1-adamantyl-D-glycine

(alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid (S)- N- Boc- 3- hydroxyadamantylglycine Boc-3-Hydroxy-1-adamantyl Saxagliptin Intermediate 3 Boc-3-Hydroxy-1-adamantyl-D-glycine Saxagliptin II Tricyclo[3.3.1.13,7]decane-1-a acid, .alpha.-[[(1,1-diMethyleth no]-3-hydroxy-, (.alpha.S)- TRICYCLO[3.3.1.13,7]DECANE-1-ACETIC ACID,.ALPHA.-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-HYDROXY- Boc-3-Hydroxy-1-adaMantyl-D-glycin (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid (S)-N-tert-Butyloxycarbonyl-3-HydroxyadaMantylglycine Tricyclo[3.3.1.13,7]decane-1-Acetic acid,.alpha.-[[(1,1-diMethyl ethoxy)carbonyl]aMino]-3-hydroxy-, (.alpha.S)- Saxagliptin INT 3 Vildagliptin interMediate D Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (αS)- 2S-N-Boc-amino-(3-Hydroxy-adamantan-1-yl)-acetic acid (S)-2-((tert-butoxycarbonyl)amino)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)aceticacid (2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.13,7]decan-1-yl)ethanoic acid Saxagliptin impurity F EOS-60797 Saxaint-G Saxaint-I (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1- Boc-(R)-2-(3-Hydroxy-1-adamantyl)glycine α‐{[(1,1‐Dimethylethoxy)‐carbonyl]‐amino}‐3‐hydroxy‐ tricyclo[3.3.113,7]decane‐1‐acetic acid (S)-2-(Boc-amino)-2-(3-hydroxy-1-adamantanyl)acetic Acid (Alpha S)-Alpha - [[ (1,1-Dimethylethyoxy)Carbonyl]Amino]-Alpha-(3-Hydroxyadamantan-1-Yl)Acetic Acid N- tert-butyloxy-3-hydroxy-1- adamantyl- D- glycine (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)aceticaci Boc-3- hydroxy-1-amantadyl - D-glycine Boc-3-Hydroxy-1-adamantyl-D-glycine(For export only) Boc-3-Hydroxy-1-adamantyl-D-glycine USP/EP/BP (S)[[(1,1-dimethylethoxy) Carbonyl]amino-3-hydroxy tricyclo[3.3.1.1]decane-1 acetic acid R-isomer of SXG acid TIANFU-CHEM Boc-3-Hydroxy-1-adamantyl-D-glycine Boc-3-Hydroxy-1-Adamantyl-D-Glycine / Saxagliptin Intermediate (2S)-[(tert-Butoxycarbonyl)amino]-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetic Acid (αS)-α[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid N-tert butoxycarbonyl-3-hydroxy-1-adamantine-D-glycine (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-aceticac ( S ) -2 - ( ( tert - butoxycarbonyl ) amino ) -2 - ( ( 1r , 3R , 5R , 7S ) -3 - hydroxyadamantan - 1 - yl ) acetic a (2S)-[(tert-butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.1 3,7]dec-1-yl)acetic acid (S)-N-Boc-3-Hydroxyadamantylglycine 98% N-tert-Butyloxycarbonyl-3-hydroxy-1-adamantyl-D-glycine (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid,98% (2S)-2-(tert-Butoxycarbonylamino)-2-(3-hydroxy-1-adamantyl)acetic acid (alphaS)-alpha[N-BOC-Amino]-3-hydroxytricyclo[3.3.1.13,7]decan-1-acetic acid Tricyclo(3.3.1.13,?)decane-1-Acetic acid, α-(((1,1-dimethylethoxy)carbonyl)amino)-3-hydroxy-, (αS)- (S)-2-((tert-Butoxycarbonyl)amino)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)acetic acid (Saxagliptin Impurity) N-tert-butoxycarbonyl-3-hydroxy-1-adamantyl-D-glycine 361442-00-4 3161442-00-4 Saxagliptin? intermediate